Full Text View
Tabular View
No Study Results Posted
Related Studies
Renal Denervation in Diabetic Nephropathy (DERENEDIAB)
This study is currently recruiting participants.
Verified March 2012 by Assistance Publique - Hôpitaux de Paris
Study NCT01588795   Information provided by Assistance Publique - Hôpitaux de Paris

First Received on April 18, 2012.   Last Updated on June 4, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Kidney Diseases
Proteinuria
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
Cholecalciferol
Diuretics
Vitamin D
Vitamins
More general drug interventions related to this trial
Bone Density Conservation Agents
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services